Changes of iron concentrations in skin and plasma of patients with hemochromatosis along therapy
- First Online:
- Cite this article as:
- Pinheiro, T., Barreiros, A., Alves, L.C. et al. J Radioanal Nucl Chem (2009) 281: 161. doi:10.1007/s10967-009-0125-4
Skin as a manageable organ can provide direct or indirect information of tissue iron overload resulting from inherited disorders as hemochromatosis. Patients with hemochromatosis were evaluated at three consecutive phases along the therapy programme. Nuclear microprobe techniques were used to assess skin iron and Total Reflection X-ray Fluorescence to determine the plasma iron concentrations. Results showed that iron pools were differently correlated at the three therapy phases. These variations highlighted the value of skin iron content to assess organ iron deposition and therapy efficacy. Skin iron content can be used for a better management of patients with iron overload pathologies.